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Protective Effect of Sauchinone Against Regional Myocardial 
Ischemia/Reperfusion Injury: Inhibition of p38 MAPK and JNK 
Death Signaling Pathways 
Sauchinone has been known to have anti-inflammatory and antioxidant effects. We 
determined whether sauchinone is beneficial in regional myocardial ischemia/reperfusion  
(I/R) injury. Rats were subjected to 20 min occlusion of the left anterior descending 
coronary artery, followed by 2 hr reperfusion. Sauchinone (10 mg/kg) was administered 
intraperitoneally 30 min before the onset of ischemia. The infarct size was measured 2 hr 
after resuming the perfusion. The expression of cell death kinases (p38 and JNK) and 
reperfusion injury salvage kinases (phosphatidylinositol-3-OH kinases-Akt, extra-cellular 
signal-regulated kinases [ERK1/2])/ glycogen synthase kinase (GSK)-3β was determined 
5 min after resuming the perfusion. Sauchinone significantly reduced the infarct size 
(29.0% ± 5.3% in the sauchinone group vs 44.4% ± 6.1% in the control, P < 0.05). 
Accordingly, the phosphorylation of JNK and p38 was significantly attenuated, while that 
of ERK1/2, Akt and GSK-3β was not affected. It is suggested that sauchinone protects 
against regional myocardial I/R injury through inhibition of phosphorylation of p38 and 
JNK death signaling pathways.
Key Words: Sauchinone; Cardioprotection; Ischemia/reperfusion Injury; Cell Death 
Signaling Pathway; Reperfusion Injury Salvage Kinase Pathway
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BRIEF COMMUNICATION
Cardiovascular Disorders
A myocardial ischemia/reperfusion (I/R) injury is a complex 
process involving the generation and release of reactive oxygen 
species and inflammatory cytokines (1). An urgent restoration 
of coronary blood flow to the ischemic area is the most effective 
strategy to improve outcomes of myocardial I/R injury. Upon 
resuming the perfusion, reperfusion injury salvage kinases (RISK) 
survival signaling pathways such as phosphatidylinositol-3-OH 
kinases (PI3K)-Akt, extra-cellular signal-regulated kinases (ERK1/ 
2), and their downstream target glycogen synthase kinase (GSK)-
3β may be activated to confer tissue protection (2). However, at 
the same time, the reperfusion may also activate ‘stress-respon-
sive’ mitogen-activated protein kinase (MAPK) subfamilies (so-
called cell death signaling pathway), i.e., c-Jun N-terminal kinases 
(JNK) and p38 MAPKs, resulting in necrosis (3). Therefore, the 
degree of I/R injury may be determined by a relative extent of 
death and survival kinases activation (4).
  Sauchinone is a biologically active lignan isolated from Saururus 
chinensis which has been long used in folk medicine for the treat-
ment of edema, jaundice, and several inflammatory diseases (5). 
It has been known to inhibit apoptotic death of C6 glioma cells 
induced by staurosporine (6) and to reduce ischemia-induced 
neuronal death via suppression of intracellular radical produc-
tion (7). We have previously shown that sauchinone inhibits lipo-
polysaccaride-induced tumor necrosis factor-α (TNF- α) expres-
sion in macrophages via suppression of NF-κB activation (8). 
  The present study aimed at examining whether sauchinone 
would provide a protection against regional myocardial I/R in-
jury. The expression of molecules related with cell survival such 
as Akt and ERK1/2/GSK-3β as well as that related with cell death 
such as JNK and p38 MAPKs was determined. 
  The procedures were carried out after the approval by the in-
stitutional animal care and use committee, Research Institute 
of Medical Science at Chonnam National University Medical 
School (Gwangju, Korea). Male Sprague-Dawley rats weighing 
250-350 g were used. They were housed in a vivarium maintained 
at 20°C-23°C with 12-hr light/dark cycle and given food and water 
ad libitum. On the experimental day, the rats were anesthetized 
with phenobarbital (100 mg/kg, intraperitoneal), and mechani-Kim SJ, et al.  •  Sauchinone and Cardioprotection
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cally ventilated with an air-oxygen mixture. The polyethylene 
catheter was cannulated into the common carotid artery for the 
arterial blood pressure monitoring and into the internal jugular 
vein for drug administration (9). Core body temperature was 
monitored with a rectal temperature probe and maintained at 
37.5°C-38.5°C using heating pad. Left thoracotomy was per-
formed at the fifth intercostal space, and 6-0 silk ligature was 
placed around left anterior descending coronary artery (LAD). 
After stabilization period of 20 min, the LAD was occluded for 
20 min and then reperfused for 2 hr. LAD occlusion was con-
firmed by ST segment changes in electrocardiogram and the 
presence of regional cyanosis in the myocardial surface. There 
were three I/R groups as shown in Fig. 1: 1) control group, 2) 
sauchinone group which received sauchinone (10 mg/kg, dis-
solved in dimethyl subfoxide [DMSO]), and 3) DMSO group 
which received vehicle only. Sauchinone was isolated from the 
n-hexane fraction of Saururus chinensis by successive silica gel 
chromatography and reverse-phase high-pressure liquid chro-
matography, and was  > 97% pure (10). The dosage of sauchi-
none adopted was effective to increase survival rates and to  
decrease the plasma level of TNF-α in mice administered lipo-
polysaccharide/D-galactosamine (10). Sauchinone and DMSO 
were administered intraperitoneally 30 min before the onset of 
ischemia. At the end of 2 hr reperfusion, the heart was quickly 
excised and mounted on a Langendorff apparatus. The LAD 
was reoccluded, and then fluorescent polymer microspheres 
were infused into the aorta to demarcate the risk zone as the tis-
sue without fluorescence. The heart was sliced into 2 mm trans-
verse sections, which were incubated at 37°C for 20 min in tri-
phenyl tetrazolium chloride in sodium phosphate buffer. The 
slices were immersed in 10% formalin to enhance the contrast 
between stained (viable) and unstained (necrotic) tissue and 
then squeezed between glass plates spaced exactly 2 mm apart. 
The myocardium at risk was identified by illuminating the slices 
with ultraviolet light. The infracted and risk zone regions were 
traced on a clear acetate sheet and quantified with Image Tool 
(San Antonio, TX, USA). The areas were converted into volumes 
by multiplying the areas by slice thickness. Infarct size is expressed 
as a percentage of the risk zone (11). 
  For immunoblotting, the heart was excised 5 min after reper-
fusion, and the risk area in the left ventricle was separated in 
each group. Myocardial samples were homogenized and equiv-
alent amounts of proteins were loaded to 10% Tris-HCl SDS poly-
acrylamide gel. Proteins were electrotransferred to a polyvinyli-
dene difluoride membrane. The membrane was then incubated 
overnight at 4°C with rat polyclonal specific primary antibodies 
to phosphorylated p38, JNK, Akt, ERK1/2 and GSK-3β (Ser
9) (Cell 
Signaling Technology; Danvers, MA, USA). It was subsequently 
incubated with anti-rabbit or anti-rat immunoglobulin HRP-
coupled secondary antibodies. Immunoreactive bands were  
visualized using ECL Western blotting detection reagents. The 
membranes were then stripped using a stripping buffer, and 
reprobed with antibodies specific for total p38, JNK, Akt, ERK1/2, 
GSK-3β and β-actin (Cell Signaling Technology). Data were ex-
pressed as means ± SD. Differences in infarct size and immunob-
lot data between groups were tested by one-way analysis of vari-
ance (ANOVA). A Scheffé test was used for multiple pair-wise 
comparisons when a significant difference was indicated with 
ANOVA. P < 0.05 was considered to be statistically significant. 
  The heart rate and arterial pressure did not significantly differ 
among the groups at any time point (data not shown). Nor did 
the ratio of the area at risk to left ventricular mass differ among 
the groups. Sauchinone significantly reduced the infarct size 
(Fig. 2). Sauchinone significantly attenuated the degree of phos-
phorylation of p38 and JNK (P < 0.05), without affecting that of 
ERK1/2, Akt and GSK-3β (Fig. 3).  
  Our study demonstrated that sauchinone has a novel protec-
tive effect against regional myocardial I/R injury in an open-chest 
rodent model. The protective effect was associated with attenu-
ated phosphorylation of cell death signaling pathways (p38 and 
JNK), without effects on that of RISK pathways (ERK1/2, Akt) 
and GSK-3β. Several recent studies have suggested that activa-
tion of p38 MAPK and JNK, known enhancers of the expression 
of adhesion molecules and the production of cytokines (12), plays 
a major role in cell death following I/R injury. The concept has 
Fig. 1. Experimental protocol. Sauchinone (10 mg/kg) and dimethyl sulfoxide (DMSO) 
were administered intraperitoneally 30 min before ischemia. 
Ischemia Reperfusion Control (n = 6)
30 min 20 min 120 min
Ischemia Reperfusion Sauchinone (n = 7)
Ischemia Reperfusion DMSO (n = 6)
Fig. 2. Effects of sauchinone on the infarct size. All rats were subjected to 20 min   
regional ischemia followed by 2 hr of reperfusion. The infarct size is expressed as a 
percentage of area at risk. Sauchinone reduced infarct size, while DMSO alone was 
without effects. Values are mean ± SD. *P < 0.05 vs control.
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been supported by the observations in which an inhibition of 
p38 activation reduced the caspase-3 activity and protected car-
diac myocytes following I/R insult in vitro (13), and improved 
postischemic cardiac function in vivo (14). It was also shown 
that an inhibition of JNK decreased ischemia-induced necrosis 
and apoptosis in myocardial I/R injury (15, 16). However, an acti-
vation of p38 MAPK or JNK has been also shown to play a pro-
tective role in I/R injury (17, 18). The distinction of beneficial 
versus detrimental role of p38 and/or JNK signaling remains to 
be further addressed.
  On the other hand, the extent of phosphorylation of Akt, ERK 
and GSK-3β induced by I/R was not affected by sauchinone in 
the present study, suggesting that RISK/GSK-3β pathways were 
not involved. The disturbance of ion homeostasis resulting from 
ATP depletion following the opening of the mitochondrial per-
meability transition pore (mPTP) can lead to necrotic and apop-
totic cell death (19). Both ischemic/pharmacological pre- and 
post-conditioning are generally perceived to protect the heart 
against I/R injury via activation of the RISK pathway involving 
PI3K-Akt and ERK1/2 at the time of reperfusion (2). Its activa-
tion may prevent cellular damages by converging on the mPTP 
through GSK-3β, which in turn inhibits its opening (19). Sauchi-
none (EC50 = 1 μM) has been shown to prevent mitochondrial 
dysfunction and apoptosis induced by iron plus arachidonic acid 
in the hepatocyte, possibly through inhibition of reactive oxygen 
species production (20). Further studies defining the role of 
mPTP in sauchinone-induced myocardial protection against   
I/R injury may be needed.  
  In summary, the present study demonstrates a cardioprotec-
tive effect of sauchinone against regional I/R injury in the rat, 
which may be related to an attenuation of cell death signaling 
pathways involving p38 and JNK but not to activation of RISK/
GSK-3β pathways. 
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